Iraq Bulletin

Category : ACCESSWIRE

ACCESSWIRE

Exosens Adds Innovative Photon Counting System, LINCam, to Its Portfolio of Single Photon Sensitive Detectors

admin
RODEN, NETHERLANDS / ACCESSWIRE / April 9, 2024 / Exosens is pleased to announce a partnership with Photonscore, a provider of instrumentation for time-correlated single photon imaging. Through this partnership, Exosens will distribute LINCam, an innovative camera system with picosecond time resolution through their Photonis-branded scientific imaging product portfolio. Exosens......
ACCESSWIRE

Participants in Nigeria Vaccinated in First-Ever Phase 2 Lassa Fever Vaccine Clinical Trial, Sponsored by IAVI

admin
The CEPI-funded study will evaluate the safety, tolerability, and immunogenicity of IAVI’s single dose Lassa fever vaccine candidate Key takeaways: Participants in Nigeria have been vaccinated with a Lassa fever vaccine candidate in the first Phase 2 clinical trial of any Lassa vaccine. Lassa fever is a deadly hemorrhagic fever......
ACCESSWIRE

4me(R) Acquires StatusCast, Adding Incident Management Capabilities to Its Leading SaaS-Based ITSM Platform

admin
The Acquisition Broadens the Reach of 4me® and Expands Its Capabilities by Integrating Real-Time Technology Service Status Updates for IT Teams, Service Providers and Customers SANTA BARBARA, CA / ACCESSWIRE / April 2, 2024 / 4me®, the SaaS-based Service Management software platform for the modern enterprise, has completed the acquisition......
ACCESSWIRE

Global Sports Brand U.S. Polo Assn. Delivers Record $2.4 Billion in Retail Sales for 2023, Targets $3 Billion and 1,500 U.S. Polo Assn. Stores

admin
WEST PALM BEACH, FL / ACCESSWIRE / April 2, 2024 / USPA Global has announced that U.S. Polo Assn., the official brand of the United States Polo Association (USPA), has delivered a record $2.4 billion in global retail sales in 2023. The global sports brand’s record growth is the result......
ACCESSWIRE

Moderna Achieves Positive Interim Results from Phase 3 Trial of Next-Generation COVID-19 Vaccine

admin
mRNA-1283 induced a more robust immune response compared to Spikevax® COVID-19 vaccine, mRNA-1273.222 Next-generation mRNA vaccine design offers the potential of longer shelf life and storage advantages, and paves the way for combination vaccine against influenza and COVID-19, mRNA-1083 CAMBRIDGE, MA / ACCESSWIRE / March 26, 2024 / Moderna, Inc.......
ACCESSWIRE

Cleverbridge and PartnerStack Launch CleverPartners to Accelerate the Growth of B2B Partner Ecosystems

admin
With acquisition costs on the rise, CleverPartners offers a pathway to sustained revenue growth by helping businesses reach more ready-to-buy prospects through cost-efficient channels. COLOGNE, GERMANY / ACCESSWIRE / March 21, 2024 / Cleverbridge, a growth engine for global technology companies, today announced the launch of CleverPartners, powered by PartnerStack,......
ACCESSWIRE

SuperMeat’s Forward-Facing LCA Highlights 50% Decrease in Carbon Footprint of Chicken, the Most Efficient Animal Protein

admin
SuperMeat’s Continuous Production Process Fuels Carbon-Efficiency Leap TEL AVIV, ISRAEL / ACCESSWIRE / March 20, 2024 / SuperMeat, a food-tech company dedicated to supplying the world with high-quality cultivated meat, today shared industry-first, forward-looking projections for cultivated chicken based on its landmark continuous production process, outperforming the ambitious benchmarks set......